Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
8719357
Reference Type
Journal Article
Title
Synthesis and evaluation of 1,4-dihydropyridine derivatives with calcium channel blocking activity
Author(s)
Bladen, C; Gündüz, MG; Şimşek, R; Şafak, C; Zamponi, GW
Year
2014
Is Peer Reviewed?
1
Journal
Pflügers Archiv: European Journal of Physiology
ISSN:
0031-6768
EISSN:
1432-2013
Volume
466
Issue
7
Page Numbers
1355-1363
Language
English
PMID
24149495
DOI
10.1007/s00424-013-1376-z
Abstract
1,4-Dihydropyridines (DHPs) are an important class of L-type calcium channel blockers that are used to treat conditions such as hypertension and angina. Their primary target in the cardiovascular system is the Cav1.2 L-type calcium channel isoform, however, a number of DHPs also block low-voltage-activated T-type calcium channels. Here, we describe the synthesis of a series of novel DHP derivatives that have a condensed 1,4-DHP ring system (hexahydroquinoline) and report on their abilities to block both L- and T-type calcium channels. Within this series of compounds, modification of a key ester moiety not only regulates the blocking affinity for both L- and T-type channels, but also allows for the development of DHPs with 30-fold selectivity for T-type channels over the L-type. Our data suggest that a condensed dihydropyridine-based scaffold may serve as a pharmacophore for a new class of T-type selective inhibitors. 2013 Springer-Verlag.
Keywords
1,4-Dihydropyridine; Aldosterone secretion.; Calcium channels; Cardiovascular; Hypertension
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity